U.S. Consumer Finance Stock News

NasdaqGS:FHB
NasdaqGS:FHBBanks

3 US Financial Stocks Retail Investors Are Watching as Rate Pressure Builds

Rising US Treasury yields, renewed pressure from $100 oil, and new tariffs from the Trump administration are putting the spotlight back on big US financial stocks, where balance sheet strength and interest rate sensitivity can quickly matter more than headlines. With expectations building around the Federal Reserve’s next move, some large banks, insurers, and asset managers could find this mix of inflation, bond market moves, and trade tension either helpful or painful. This article explains...
NYSE:TEL
NYSE:TELElectronic

TE Connectivity (TEL) Could Be 21% Undervalued After Strong Q3 Results And Buybacks

Fresh interest in TE Connectivity (TEL) stock follows a busy stretch, with the company reporting third quarter results, continuing its buyback activity, and seeing increasing analyst optimism around its earnings outlook and valuation. See our latest analysis for TE Connectivity. Against this backdrop of strong third quarter results and ongoing buybacks, TE Connectivity’s 1 day share price return of 2.09% stands in contrast to a year to date share price decline of 12.98%. At the same time, the...
NYSE:UNP
NYSE:UNPTransportation

Union Pacific (UNP) Stock Faces Slower Revenue Growth Narrative Despite 28.8% Net Margin

Union Pacific (UNP) has put solid numbers on the board for Q2 2026, with revenue of US$6.9 billion, basic EPS of US$3.36 and net income of US$2.0 billion. On a trailing twelve month basis, revenue sits at US$25.4 billion with basic EPS of US$12.36 and net income of US$7.3 billion. The company has seen quarterly revenue move from US$6.2 billion in Q1 2026 to US$6.9 billion in Q2 2026, alongside basic EPS rising from US$2.87 to US$3.36 over the same period. This gives investors a clear view of...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is Elanco Animal Health (ELAN) Still A Bargain After 108% Gains?

Elanco Animal Health stock has delivered a 107.8% return over the past three years, yet the current valuation checks and intrinsic value work suggest the shares may still be trading below what the business could be worth on fundamentals. Over the past three years, Elanco Animal Health has returned 107.8%, which puts recent price action front and center for anyone weighing up what is already reflected in the share price. For valuation, the key upside driver is how effectively Elanco Animal...
NasdaqGS:PRGS
NasdaqGS:PRGSSoftware

Progress Software (PRGS) Stock Looks Fairly Priced With Earnings At A Discount

Progress Software stock has retreated over the past three years. On current checks it does not look obviously expensive or obviously cheap, which puts more weight on how investors read the latest moves around its valuation. The recent agreement to acquire Domo for US$400 million adds a fresh piece to that puzzle for anyone weighing what the current share price implies. Progress Software shares are down about 34.2% over three years, which suggests investors have become more cautious about the...
NYSE:TOST
NYSE:TOSTDiversified Financial

Toast’s Earnings Focus and All‑in‑One Restaurant Platform Could Be A Game Changer For Toast (TOST)

Recently, Toast drew attention as investors weighed its upcoming August 4, 2026 earnings release, which is expected to show higher earnings per share and revenue than the prior year, alongside debate over its valuation relative to peers. At the same time, comparisons with competitor Dave have highlighted Toast’s broad restaurant ecosystem, spanning payments, software, hardware, lending, and AI tools, as a key differentiator that could influence how its long-term business quality is...
NasdaqGS:AKTS
NasdaqGS:AKTSBiotechs

Is Aktis Oncology (AKTS) Fairly Valued After Its Recent Pullback?

Aktis Oncology (AKTS) has drawn investor attention after recent trading swings, with the stock down 4% over the past week and around 17% over the past month, despite year-to-date gains. See our latest analysis for Aktis Oncology. The recent 30 day share price return of down 16.8% has cooled earlier gains, even though the 90 day share price return of 12.4% and 6.7% year to date still point to fading, but not fully reversed, momentum for Aktis Oncology around the latest close at $23.89. If you...
NasdaqGS:VOR
NasdaqGS:VORBiotechs

Vor Biopharma (VOR) Stock May Already Look Fully Priced On Pipeline Hopes

Vor Biopharma stock has delivered a steeply negative 5 year return even after a recent rebound, and the low overall value score suggests the current share price of US$19.26 is not an obvious bargain based on the standard checks used here. Vor Biopharma has fallen 92.3% over 5 years, which puts the recent short term gains into the context of a share price that has already given up a large amount of value. Expectations around the company’s ability to translate its pipeline into sustainable...
NYSE:LU
NYSE:LUConsumer Finance

What Lufax Holding (LU)'s CFO Exit and Board Reshuffle Means For Shareholders

Lufax Holding Ltd. recently announced that four directors, including executive director and chief financial officer Tongzhuan Xi, resigned citing personal work arrangements, while the company began a CFO search and reshuffled key board committee roles. At the same time, Lufax appointed veteran risk and governance specialist Wai Kin Chim as an independent non-executive director, potentially reshaping board oversight and control. We will now examine how the leadership reshuffle, particularly...
NasdaqGS:VICR
NasdaqGS:VICRElectrical

AppLovin Stock Leads 3 High Growth Picks With Strong Earnings Outlook

With inflation signals mixed, tariffs back in the headlines and borrowing costs still shaping consumer and business decisions, many investors are looking for stocks where analysts see clear earnings growth potential and balance sheets that can handle bumps in the road. That is exactly what the Healthy high growth potential screener aims to capture. It does this by filtering for companies where analysts expect strong earnings growth over the next 3 years and financial positions that meet...
NYSE:XYZ
NYSE:XYZDiversified Financial

Block (SQ) Could Be 15% Below Fair Value Following Square Client Expansion

Block (SQ) is back in focus after two restaurant and retail clients, Honolulu Cookie Company and Dimassi’s Mediterranean Buffet, expanded their use of Square’s software, hardware, and marketing tools across growing store networks. See our latest analysis for Block. Despite recent client wins, Block’s share price has moved in fits and starts, with a 90 day share price return of 7.71% and an 18.42% year to date share price return. The 5 year total shareholder return has declined 68.80%,...
NYSE:FPS
NYSE:FPSElectrical

Is Forgent Power Solutions (FPS) Cheap After Record AI Backlog Growth?

Forgent Power Solutions (FPS) has drawn investor attention after reporting exceptionally strong demand tied to AI data centers and grid infrastructure, with record bookings and a nearly $2b backlog that supports revenue visibility and operational momentum. See our latest analysis for Forgent Power Solutions. Despite strong interest around AI data centers and grid projects, Forgent Power Solutions’ recent share price return has been mixed, with the stock down over the past month but still...
NYSE:ETSY
NYSE:ETSYMultiline Retail

How Rising Optimism Around Another Earnings Beat At Etsy (ETSY) Has Changed Its Investment Story

Recently, analysts grew more optimistic about Etsy’s upcoming quarterly earnings, pointing to the company’s history of outperforming estimates and a positive Earnings ESP alongside a favorable Zacks Rank. This shift in sentiment highlights how Etsy’s pattern of beating expectations is shaping perceptions of its earnings quality, rather than just its headline results. We’ll now examine how growing analyst optimism about another potential earnings beat could influence Etsy’s broader investment...
NYSE:SPOT
NYSE:SPOTEntertainment

Spotify Technology (SPOT) Removed Fake Streams, Is The Stock Still Overvalued?

Spotify Technology (SPOT) is back in focus after the company reportedly removed more than 500,000 fake streams from Malcolm Todd’s “Earrings,” an episode tied to a regulated prediction market and potential legal questions. See our latest analysis for Spotify Technology. The share price of Spotify Technology has been volatile, with a 1-day share price return of 2.91% and a 30-day share price return of 6.08%. It is still down 16.06% year to date, and the 1-year total shareholder return has...
NYSE:PG
NYSE:PGHousehold Products

Samsung Stock And 2 Global Brands Facing Fresh Tariff Pressure

New US tariffs on imports from more than 60 economies are reshaping the risk profile for many global stocks, especially those built on complex cross border supply chains. Higher duties, possible retaliation, and added compliance hurdles can all eat into margins and unsettle earnings expectations. For investors, that can mean additional reasons to reassess which multinational companies might carry more risk than their share price suggests. This article looks at 3 stocks exposed to the latest...
NYSE:PINS
NYSE:PINSInteractive Media and Services

Pinterest (PINS) Could Be 20% Undervalued As Earnings Approach

Pinterest (PINS) is drawing fresh attention ahead of its second quarter earnings report, as investors weigh easier year ago comparisons against ongoing questions about ad monetization and the role of AI on the platform. See our latest analysis for Pinterest. At a share price of US$22.13, Pinterest has recently shown a 1 month share price return of 11.43% and a 3 month share price return of 11.09%. However, its 1 year total shareholder return is down 41.62%, which points to improving short...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Is Teladoc Health (TDOC) Undervalued As Teladoc One Tests The AI Health Threat?

Teladoc Health (TDOC) is back in focus after unveiling Teladoc One, an AI supported virtual care platform, just as new tools like ChatGPT Health raise questions about how patients seek digital health advice. See our latest analysis for Teladoc Health. Teladoc Health’s recent Teladoc One announcement and the spotlight on ChatGPT Health come after a strong 90 day share price return of 52.52% and a year to date share price return of 24.40%, while the 5 year total shareholder return is down...
NYSE:OSCR
NYSE:OSCRInsurance

Oscar Health (OSCR) Stock Still Trades At A Discount As Growth Meets Cost Questions

Oscar Health stock has delivered a very large 3-year gain, yet the broader valuation checks paint a more mixed picture, with the shares currently screening as undervalued on market multiples but only middling on a composite value score. Over the last 3 years, Oscar Health has returned roughly 2.8x an investor's starting position. This puts recent moves in a longer-term context that matters for today's entry price. Expectations around how efficiently Oscar Health can scale its insurance...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Is Duolingo’s (DUOL) AI-Boosted Youth Engagement Quietly Reshaping Its Long-Term Growth Narrative?

In July 2026, app analytics firm Apptopia reported that Duolingo’s average time spent per daily active user among 17-to-25-year-olds reached its highest level since January 2025, with heavy AI chatbot users also increasing their engagement. This suggests that rather than replacing language learning apps, AI chatbots may be reinforcing Duolingo’s appeal for younger, highly engaged learners. We’ll now examine how this surge in AI-driven engagement among young users might influence Duolingo’s...
NYSE:UNFI
NYSE:UNFIConsumer Retailing

United Natural Foods (UNFI) Stock May Still Be A Bargain On Sales

United Natural Foods has delivered a strong 139.7% return over the past 3 years, and with the stock recently closing at US$49.67, the key question is whether that share price still sits below what its fundamentals imply or if most of the easy value has already been recognised. A 139.7% return over 3 years suggests investors who bought earlier have been well rewarded, so new buyers now need to think carefully about what is already reflected in the price. For a distributor with typically thin...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Grab Holdings (GRAB) Heads Into Earnings As Undervaluation Hopes Meet A Pricey P/E

Investor attention has turned to Grab Holdings (NasdaqGS:GRAB) as the company approaches its August 3, 2026 earnings release, while recent analyst estimate revisions contrast with a mild pullback in the share price. See our latest analysis for Grab Holdings. Over the past year, Grab Holdings has seen its share price fall 34.84% year to date and its 1 year total shareholder return decline 38.25%. At the same time, the recent 7 day and 90 day share price returns of 7.28% and 15.13% respectively...
NasdaqCM:NESR
NasdaqCM:NESREnergy Services

Is National Energy Services Reunited (NESR) Undervalued As Its Long Contract Story Builds?

National Energy Services Reunited (NESR) is back in focus after the company announced that Maen Razouqi will join its board as an additional independent director, effective August 1, 2026. See our latest analysis for National Energy Services Reunited. Against this backdrop, National Energy Services Reunited’s recent board appointment comes as the stock trades at US$27.62, with a 30 day share price return of 9.73% and a year to date share price return of 74.92%. The 1 year total shareholder...
NYSE:PNC
NYSE:PNCBanks

Is PNC Financial Services Group (PNC) Undervalued On Strong Second Quarter Earnings?

PNC Financial Services Group (PNC) stock has been in focus after strong second quarter earnings, with higher net interest income and net income, and a recent move above its 20 day moving average. See our latest analysis for PNC Financial Services Group. At a latest share price of $250.99, PNC Financial Services Group has a 30 day share price return of 4.61% and a 90 day share price return of 14.16%. The 1 year total shareholder return of 32.24% and 3 year total shareholder return of about 11x...
NasdaqGS:SPCX
NasdaqGS:SPCXTelecom

SpaceX (NasdaqGS:SPCX) Stock Still Looks Expensive After A 29% Fall

Space Exploration Technologies stock has already fallen 28.5% year to date, yet the shares still screen as expensive on broader valuation checks, putting the recent selloff in tension with what the current multiples are implying about future expectations. The year to date decline of 28.5% suggests sentiment has swung sharply away from Space Exploration Technologies after an early burst of enthusiasm around the IPO. Expectations around Starlink and orbital AI data centers can support a rich...